Corrigendum to “Differential susceptibility to acetaminophen-induced liver injury in sub-strains of C57BL/6 mice6N versus 6J” [Food and Chem. Toxicol. 98 (Part B) (2016) 107–118] (S0278691516303805)(10.1016/j.fct.2016.10.021);Differential susceptibility to acetaminophen-induced liver injury in sub-strains of C57BL/6 mice: 6N versus 6J

Food and Chemical Toxicology

Volumn 98, Issue , 2016, Pages 107-118

  Duan, Luqi ^a   Davis, John S ^b,c   Woolbright, Benjamin L ^a   Du, Kuo ^a   Cahkraborty, Mala ^b   Weemhoff, James ^a   Jaeschke, Hartmut ^a   Bourdi, Mohammed ^b,d  

^a Department of Pharmacology   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Acetaminophen hepatotoxicity; C57BL 6 sub strains; DNA fragmentation; Mitochondrial dysfunction; Protein adducts

Indexed keywords

ALANINE AMINOTRANSFERASE; APOPTOSIS INDUCING FACTOR; CYTOCHROME P450; GLUTATHIONE; GLUTATHIONE DISULFIDE; PARACETAMOL; PROTEIN BAX; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; STRESS ACTIVATED PROTEIN KINASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; C57BL/6N MOUSE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA FRAGMENTATION; GLUTATHIONE METABOLISM; HISTOPATHOLOGY; LIVER CELL; LIVER INJURY; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; STRAIN DIFFERENCE; ANIMAL; C57BL MOUSE; CHEMICAL AND DRUG INDUCED LIVER INJURY; COMPARATIVE STUDY; DRUG EFFECTS; ENZYME IMMUNOASSAY; HUMAN; LIVER MITOCHONDRION; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; WESTERN BLOTTING;

ACETAMINOPHEN; ANIMALS; BLOTTING, WESTERN; CHEMICAL AND DRUG INDUCED LIVER INJURY; DISEASE SUSCEPTIBILITY; GLUTATHIONE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA, LIVER; OXIDATIVE STRESS;

EID: 84993985703     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2017.03.032     Document Type: Erratum

References (60)

1. Antoine, D.J., Dear, J.W., Lewis, P.S., Platt, V., Coyle, J., Masson, M., Thanacoody, R.H., Gray, A.J., Webb, D.J., Moggs, J.G., Bateman, D.N., Goldring, C.E., Park, B.K., Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology 58 (2013), 777–787.
2. Antoine, D.J., Jenkins, R.E., Dear, J.W., Williams, D.P., McGill, M.R., Sharpe, M.R., Craig, D.G., Simpson, K.J., Jaeschke, H., Park, B.K., Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J. Hepatol. 56 (2012), 1070–1079.
3. Bajt, M.L., Cover, C., Lemasters, J.J., Jaeschke, H., Nuclear translocation of endonuclease G and apoptosis-inducing factor during acetaminophen-induced liver cell injury. Toxicol. Sci. 94 (2006), 217–225.
4. Bajt, M.L., Farhood, A., Lemasters, J.J., Jaeschke, H., Mitochondrial bax translocation accelerates DNA fragmentation and cell necrosis in a murine model of acetaminophen hepatotoxicity. J. Pharmacol. Exp. Ther. 324 (2008), 8–14.
5. Bajt, M.L., Knight, T.R., Lemasters, J.J., Jaeschke, H., Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine. Toxicol. Sci. 80 (2004), 343–349.
6. Bajt, M.L., Ramachandran, A., Yan, H.M., Lebofsky, M., Farhood, A., Lemasters, J.J., Jaeschke, H., Apoptosis-inducing factor modulates mitochondrial oxidant stress in acetaminophen hepatotoxicity. Toxicol. Sci. 122 (2011), 598–605.
7. Beger, R.D., Bhattacharyya, S., Yang, X., Gill, P.S., Schnackenberg, L.K., Sun, J., James, L.P., Translational biomarkers of acetaminophen-induced acute liver injury. Arch. Toxicol. 89 (2015), 1497–1522.
8. Bessems, J.G., Vermeulen, N.P., Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit. Rev. Toxicol. 31 (2001), 55–138.
9. Bourdi, M., Davies, J.S., Pohl, L.R., Mispairing C57BL/6 substrains of genetically engineered mice and wild-type controls can lead to confounding results as it did in studies of JNK2 in acetaminophen and concanavalin A liver injury. Chem. Res. Toxicol. 24 (2011), 794–796.
10. Bourdi, M., Korrapati, M.C., Chakraborty, M., Yee, S.B., Pohl, L.R., Protective role of c-Jun N-terminal kinase 2 in acetaminophen-induced liver injury. Biochem. Biophys. Res. Commun. 374 (2008), 6–10.
11. Buters, J.T., Schiller, C.D., Chou, R.C., A highly sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog and man. Direct fluorescence monitoring of the deethylation of 7-ethoxy-4-trifluoromethylcoumarin. Biochem. Pharmacol. 46 (1993), 1577–1584.
12. Cover, C., Mansouri, A., Knight, T.R., Bajt, M.L., Lemasters, J.J., Pessayre, D., Jaeschke, H., Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity. J. Pharmacol. Exp. Ther. 315 (2005), 879–887.
13. Cohen, S.D., Pumford, N.R., Khairallah, E.A., Boekelheide, K., Pohl, L.R., Amouzadeh, H.R., Hinson, J.A., Selective protein covalent binding and target organ toxicity. Toxicol. Appl. Pharmacol. 143 (1997), 1–12.
14. Dahlin, D.C., Miwa, G.T., Lu, A.Y., Nelson, S.D., N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc. Natl. Acad. Sci. U. S. A. 81 (1984), 1327–1331.
15. Fontaine, D.A., Davis, D.B., Attention to background strain is essential for metabolic research: C57BL/6 and the International Knockout Mouse Consortium. Diabetes 65 (2016), 25–33.
16. Freeman, H.C., Hugill, A., Dear, N.T., Ashcroft, F.M., Cox, R.D., Deletion of nicotinamide nucleotide transhydrogenase: a new quantitive trait locus accounting for glucose intolerance in C57BL/6J mice. Diabetes 55 (2006), 2153–2156.
17. Gujral, J.S., Knight, T.R., Farhood, A., Bajt, M.L., Jaeschke, H., Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis?. Toxicol. Sci. 67 (2002), 322–328.
18. Gunawan, B.K., Liu, Z.X., Han, D., Hanawa, N., Gaarde, W.A., Kaplowitz, N., c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology 131 (2006), 165–178.
19. Han, D., Dara, L., Win, S., Than, T.A., Yuan, L., Abbasi, S.Q., Liu, Z.X., Kaplowitz, N., Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria. Trends Pharmacol. Sci. 34 (2013), 243–253.
20. Hanawa, N., Shinohara, M., Saberi, B., Gaarde, W.A., Han, D., Kaplowitz, N., Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J. Biol. Chem. 283 (2008), 13565–13577.
21. Harrill, A.H., Ross, P.K., Gatti, D.M., Threadgill, D.W., Rusyn, I., Population-based discovery of toxicogenomics biomarkers for hepatotoxicity using a laboratory strain diversity panel. Toxicol. Sci. 110 (2009), 235–243.
22. Harrill, A.H., Watkins, P.B., Su, S., Ross, P.K., Harbourt, D.E., Stylianou, I.M., Boorman, G.A., Russo, M.W., Sackler, R.S., Harris, S.C., Smith, P.C., Tennant, R., Bogue, M., Paigen, K., Harris, C., Contractor, T., Wiltshire, T., Rusyn, I., Threadgill, D.W., Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans. Genome Res. 19 (2009), 1507–1515.
23. Henderson, N.C., Pollock, K.J., Frew, J., Mackinnon, A.C., Flavell, R.A., Davis, R.J., Sethi, T., Simpson, K.J., Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure. Gut 56 (2007), 982–990.
24. Hu, J., Ramshesh, V.K., McGill, M.R., Jaeschke, H., Lemasters, J.J., Low dose acetaminophen induces reversible mitochondrial dysfunction associated with transient c-jun N-terminal kinase activation in mouse liver. Toxicol. Sci. 150 (2016), 204–215.
25. Jaeschke, H., Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. J. Pharmacol. Exp. Ther. 255 (1990), 935–941.
26. Jaeschke, H., McGill, M.R., Ramachandran, A., Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab. Rev. 44 (2012), 88–106.
27. Jaeschke, H., Mitchell, J.R., Use of isolated perfused organs in hypoxia and ischemia/reperfusion oxidant stress. Methods Enzymol. 186 (1990), 752–759.
28. Jollow, D.J., Mitchell, J.R., Potter, W.Z., Davis, D.C., Gillette, J.R., Brodie, B.B., Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Ther. 187 (1973), 195–202.
29. Kon, K., Kim, J.S., Jaeschke, H., Lemasters, J.J., Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology 40 (2004), 1170–1179.
30. Lee, W.M., Drug-induced acute liver failure. Clin. Liver Dis. 17 (2013), 575–586.
31. LoGuidice, A., Boelsterli, U.A., Acetaminophen overdose-induced liver injury in mice is mediated by peroxynitrite independently of the cyclophilin D-regulated permeability transition. Hepatology 54 (2011), 969–978.
32. McGill, M.R., Jaeschke, H., Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm. Res. 30 (2013), 2174–2187.
33. McGill, M.R., Jaeschke, H., Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients. Expert Opin. Drug Metab. Toxicol. 10 (2014), 1005–1017.
34. McGill, M.R., Lebofsky, M., Norris, H.R., Slawson, M.H., Bajt, M.L., Xie, Y., Williams, C.D., Wilkins, D.G., Rollins, D.E., Jaeschke, H., Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications. Toxicol. Appl. Pharmacol. 269 (2013), 240–249.
35. McGill, M.R., Sharpe, M.R., Williams, C.D., Taha, M., Curry, S.C., Jaeschke, H., The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J. Clin. Invest. 122 (2012), 1574–1583.
36. McGill, M.R., Staggs, V.S., Sharpe, M.R., Lee, W.M., Jaeschke, H., Acute Liver Failure Study Group. Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome. Hepatology 60 (2014), 1336–1345.
37. McGill, M.R., Yan, H.M., Ramachandran, A., Murray, G.J., Rollins, D.E., Jaeschke, H., HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity. Hepatology 53 (2011), 974–982.
38. Mitchell, J.R., Jollow, D.J., Potter, W.Z., Davis, D.C., Gillette, J.R., Brodie, B.B., Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187 (1973), 185–194.
39. Mitchell, J.R., Jollow, D.J., Potter, W.Z., Gillette, J.R., Brodie, B.B., Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J. Pharmacol. Exp. Ther. 187 (1973), 211–217.
40. Muldrew, K.L., James, L.P., Coop, L., McCullough, S.S., Hendrickson, H.P., Hinson, J.A., Mayeux, P.R., Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection. Drug Metab. Dispos. 30 (2002), 446–451.
41. Nelson, S.D., Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin. Liver Dis. 10 (1990), 267–278.
42. Newberry, E.P., Kennedy, S., Xie, Y., Luo, J., Jiang, H., Ory, D.S., Davidson, N.O., Phenotypic divergence in two lines of L-Fabp-/- mice reflects substrain differences and environmental modifiers. Am. J. Physiol. Gastrointest. Liver Physiol. 309 (2015), G648–G661.
43. Ni, H.M., Bockus, A., Boggess, N., Jaeschke, H., Ding, W.X., Activation of autophagy protects against acetaminophen-induced hepatotoxicity. Hepatology 55 (2012), 222–232.
44. Ni, H.M., Boggess, N., McGill, M.R., Lebofsky, M., Borude, P., Apte, U., Jaeschke, H., Ding, W.X., Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury. Toxicol. Sci. 127 (2012), 438–450.
45. Ni, H.M., Chen, X., Ding, W.X., Schuchmann, M., Yin, X.M., Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice. Am. J. Pathol. 173 (2008), 962–972.
46. Ni, H.M., McGill, M.R., Chao, X., Du, K., Williams, J.A., Xie, Y., Jaeschke, H., Ding, W.X., Removal of acetaminophen protein adducts by autophagy protects against acetaminophen-induced liver injury in mice. J. Hepatol. 65 (2016), 354–362.
47. Ramachandran, A., Lebofsky, M., Baines, C.P., Lemasters, J.J., Jaeschke, H., Cyclophilin D deficiency protects against acetaminophen-induced oxidant stress and liver injury. Free Radic. Res. 45 (2011), 156–164.
48. Ray, S.D., Sorge, C.L., Raucy, J.L., Corcoran, G.B., Early loss of large genomic DNA in vivo with accumulation of Ca2+ in the nucleus during acetaminophen-induced liver injury. Toxicol. Appl. Pharmacol. 106 (1990), 346–351.
49. Rosen, G.M., Rauckman, E.J., Ellington, S.P., Dahlin, D.C., Christie, J.L., Nelson, S.D., Reduction and glutathione conjugation reactions of N-acetyl-p-benzoquinone imine and two dimethylated analogues. Mol. Pharmacol. 25 (1984), 151–157.
50. Saito, C., Lemasters, J.J., Jaeschke, H., c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity. Toxicol. Appl. Pharmacol. 246 (2010), 8–17.
51. Sharma, M., Gadang, V., Jaeschke, A., Critical role for mixed-lineage kinase 3 in acetaminophen-induced hepatotoxicity. Mol. Pharmacol. 82 (2012), 1001–1007.
52. Simon, M.M., Greenaway, S., White, J.K., Fuchs, H., Gailus-Durner, V., Wells, S., Sorg, T., Wong, K., Bedu, E., Cartwright, E.J., Dacquin, R., Djebali, S., Estabel, J., Graw, J., Ingham, N.J., Jackson, I.J., Lengeling, A., Mandillo, S., Marvel, J., Meziane, H., Preitner, F., Puk, O., Roux, M., Adams, D.J., Atkins, S., Ayadi, A., Becker, L., Blake, A., Brooker, D., Cater, H., Champy, M.F., Combe, R., Danecek, P., di Fenza, A., Gates, H., Gerdin, A.K., Golini, E., Hancock, J.M., Hans, W., Hölter, S.M., Hough, T., Jurdic, P., Keane, T.M., Morgan, H., Müller, W., Neff, F., Nicholson, G., Pasche, B., Roberson, L.A., Rozman, J., Sanderson, M., Santos, L., Selloum, M., Shannon, C., Southwell, A., Tocchini-Valentini, G.P., Vancollie, V.E., Westerberg, H., Wurst, W., Zi, M., Yalcin, B., Ramirez-Solis, R., Steel, K.P., Mallon, A.M., de Angelis, M.H., Herault, Y., Brown, S.D., A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains. Genome Biol., 14, 2013, R82.
53. Tirmenstein, M.A., Nelson, S.D., Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3'-hydroxyacetanilide, in mouse liver. J. Biol. Chem. 264 (1989), 9814–9819.
54. Vanden Berghe, T., Hulpiau, P., Martens, L., Vandenbroucke, R.E., Van Wonterghem, E., Perry, S.W., Bruggeman, I., Divert, T., Choi, S.M., Vuylsteke, M., Shestopalov, V.I., Libert, C., Vandenabeele, P., Passenger mutations confound interpretation of all genetically modified congenic mice. Immunity 43 (2015), 200–209.
55. Win, S., Than, T.A., Han, D., Petrovic, L.M., Kaplowitz, N., c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice. J. Biol. Chem. 286 (2011), 35071–35078.
56. Xie, Y., McGill, M.R., Dorko, K., Kumer, S.C., Schmitt, T.M., Forster, J., Jaeschke, H., Mechanisms of acetaminophen-induced cell death in primary human hepatocytes. Toxicol. Appl. Pharmacol. 279 (2014), 266–274.
57. Xie, Y., McGill, M.R., Du, K., Dorko, K., Kumer, S.C., Schmitt, T.M., Ding, W.X., Jaeschke, H., Mitochondrial protein adducts formation and mitochondrial dysfunction during N-acetyl-m-aminophenol (AMAP)-induced hepatotoxicity in primary human hepatocytes. Toxicol. Appl. Pharmacol. 289 (2015), 213–222.
58. Xie, Y., Ramachandran, A., Breckenridge, D.G., Liles, J.T., Lebofsky, M., Farhood, A., Jaeschke, H., Inhibitor of apoptosis signal-regulating kinase 1 protects against acetaminophen-induced liver injury. Toxicol. Appl. Pharmacol. 286 (2015), 1–9.
59. Zaher, H., Buters, J.T., Ward, J.M., Bruno, M.K., Lucas, A.M., Stern, S.T., Cohen, S.D., Gonzalez, F.J., Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Toxicol. Appl. Pharmacol. 152 (1998), 193–199.
60. Zurita, E., Chagoyen, M., Cantero, M., Alonso, R., González-Neira, A., López-Jiménez, A., López-Moreno, J.A., Landel, C.P., Benítez, J., Pazos, F., Montoliu, L., Genetic polymorphisms among C57BL/6 mouse inbred strains. Transgenic Res. 20 (2011), 481–489.